CordenPharma
Global CDMO for peptides, lipids, oligonucleotides, injectables, and small molecules.
Full-service CDMO offering cGMP development and manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligonucleotides, and oral solid dose across 10 facilities in 6 countries with 3000+ employees.
Modalities
Development & manufacturing
Structured CDMO capabilities from verified public sources.
Manufacturing (M)
Synthetic chemistry infrastructure
- Capabilities
- HPAPIFlow Chemistry
Fill-finish formats
Regulatory clearances
Services
- Small Molecule Development & Manufacturing
- Flow Chemistry & Continuous Manufacturing
- Solid-State Chemistry & Polymorph Screening
- Formulation Development
- Oral Solid Dosage Manufacturing
- Lyophilization (Freeze Drying)
- Vial Filling
- Sterile Fill-Finish & Aseptic Manufacturing
- Secondary Packaging & Labeling
- Serialization & Track-and-Trace
- Peptide Manufacturing
- Oligonucleotide Manufacturing
- Lipid Nanoparticle (LNP) Formulation
- HPAPI Manufacturing (High-Potency)
- API Synthesis & Manufacturing
- Inhalation & Nasal Dosage Manufacturing
- Process Development
- Technology Transfer
- CMC Regulatory Submission Support
- CMC Analytical Development
- Prefilled Syringe (PFS) Filling
About this organization
Overview
CordenPharma is a globally-integrated CDMO founded in 2006, supporting pharmaceutical and biotechnology customers from early clinical-phase development through commercialization. The company operates 10 cGMP manufacturing facilities across Europe and North America with over 3000 employees.
Capabilities
CordenPharma provides complex modality support including:
- Peptides — synthesis and manufacturing
- Lipids & LNPs — lipid excipient development and manufacturing
- Oligonucleotides — development and cGMP manufacturing
- Injectables — formulation and fill-finish
- Small Molecules — including highly potent APIs (HPAPI)
- Oral Solid Dose (OSD) — development and manufacturing
- Drug Products — complete formulation and manufacturing support
- Packaging Services — secondary packaging and associated services
Organization
Capabilities are organized under six Technology Platforms, each led by a Platform Director. The company emphasizes scientific expertise, cutting-edge technologies, and partnership-driven outsourcing spanning the complete supply chain from development to commercialization.
Certifications
Locations
Global Network
Recent news about CordenPharma
Related companies
Similar profiles by shared services, modalities, and capabilities.
Almac Group- Small Molecule Development & Manufacturing
- Flow Chemistry & Continuous Manufacturing
- Asymchem Laboratories
- Flow Chemistry & Continuous Manufacturing
- Formulation Development
- BSP Pharmaceuticals
- Small Molecule Development & Manufacturing
- Formulation Development
PharmaBlock- Small Molecule Development & Manufacturing
- Flow Chemistry & Continuous Manufacturing
Quotient Sciences- Small Molecule Development & Manufacturing
- Formulation Development
Dalton Pharma Services- Small Molecule Development & Manufacturing
- Flow Chemistry & Continuous Manufacturing
Ascendia Pharmaceutical Solutions- Formulation Development
- Oral Solid Dosage Manufacturing
Delpharm- Formulation Development
- Oral Solid Dosage Manufacturing
Submit a verified review for this organization.
Markdown mirror: /companies/cordenpharma.md